Construction and validation of a three-gene prognostic model based on mitochondrial RNA modification co-expression signatures in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) remains a severe global health burden. Mitochondrial RNA modification (MRM) may contribute to tumor development by altering mitochondrial activity. We investigated whether gene-expression features related to MRM could be used to generate an HCC prognostic signature and characterize its association with the tumor immune microenvironment. Public training and validation cohorts, together with MRM-related genes (MRM-RGs), were retrieved. Differentially expressed genes (DEGs) were identified, and MRM-coexpressed DEGs were obtained by intersecting DEGs with key module genes selected by WGCNA. Prognostic candidates were filtered through stepwise analyses before risk-model establishment, validation, independent prognostic assessment, and nomogram construction. Differences between the high- and low-risk groups were examined, including prognostic-gene expression and proinflammatory factor patterns. qRT-PCR and immunohistochemistry were then used to verify prognostic gene expression, and clinical associations were analyzed. A three-gene signature (GHR, ADRA1A, DBH) was identified. The risk score independently predicted survival, together with T stage; the nomogram showed acceptable calibration and moderate discrimination. High-risk patients displayed enriched proliferative pathways, increased M0 macrophages and regulatory T cells (Tregs), higher TIDE and exclusion scores, and upregulated IL-1β/IL-1α. Low expression of these genes in HCC was confirmed, and was associated with high alpha-fetoprotein (AFP), poor differentiation, and advanced tumor stage. Significant correlations with multiple MRM-related genes were observed. This three-gene signature, derived from MRM-associated co-expression patterns, was associated with HCC prognosis and may provide a potential reference for patient stratification and immunotherapy-related research; however, these findings are correlative and require further validation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-17
DOI
https://doi.org/10.1007/s12672-026-06276-3
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Construction and validation of a three-gene prognostic model based on mitochondrial RNA modification co-expression signatures in hepatocellular carcinoma

高英堂, Chenxuan Wu, Tao Han, Yue Qi
3 links
Discover Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

Construction and validation of a three-gene prognostic model based on mitochondrial RNA modification co-expression signatures in hepatocellular carcinoma

高英堂, Chenxuan Wu, Tao Han, Yue Qi
article en

Abstract

Hepatocellular carcinoma (HCC) remains a severe global health burden. Mitochondrial RNA modification (MRM) may contribute to tumor development by altering mitochondrial activity. We investigated whether gene-expression features related to MRM could be used to generate an HCC prognostic signature and characterize its association with the tumor immune microenvironment. Public training and validation cohorts, together with MRM-related genes (MRM-RGs), were retrieved. Differentially expressed genes (DEGs) were identified, and MRM-coexpressed DEGs were obtained by intersecting DEGs with key module genes selected by WGCNA. Prognostic candidates were filtered through stepwise analyses before risk-model establishment, validation, independent prognostic assessment, and nomogram construction. Differences between the high- and low-risk groups were examined, including prognostic-gene expression and proinflammatory factor patterns. qRT-PCR and immunohistochemistry were then used to verify prognostic gene expression, and clinical associations were analyzed. A three-gene signature (GHR, ADRA1A, DBH) was identified. The risk score independently predicted survival, together with T stage; the nomogram showed acceptable calibration and moderate discrimination. High-risk patients displayed enriched proliferative pathways, increased M0 macrophages and regulatory T cells (Tregs), higher TIDE and exclusion scores, and upregulated IL-1β/IL-1α. Low expression of these genes in HCC was confirmed, and was associated with high alpha-fetoprotein (AFP), poor differentiation, and advanced tumor stage. Significant correlations with multiple MRM-related genes were observed. This three-gene signature, derived from MRM-associated co-expression patterns, was associated with HCC prognosis and may provide a potential reference for patient stratification and immunotherapy-related research; however, these findings are correlative and require further validation.

Discover Oncology
Tianjin Third Central Hospital (CN), Tianjin Medical University (CN)
Good health and well-being
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon